Role of the mucous/glycocalyx layers in insulin permeation across the rat ileal membrane

被引:25
作者
Aoki, Y
Morishita, M
Takayama, K
机构
[1] Hoshi Univ, Dept Pharmaceut, Tokyo 1428501, Japan
[2] Kyorin Pharmaceut Co Ltd, Res Ctr, Nogi, Tochigi 3290114, Japan
关键词
insulin; hyaluronidase; mucous; glycocalyx; macromolecular drug delivery; intestinal metabolism; aprotinin;
D O I
10.1016/j.ijpharm.2005.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The contribution of mucous/glycocalyx layers, as a diffusional or enzymatic barrier, to the absorption of insulin was investigated in situ and in vitro studies using rats. To remove the mucous/glycocalyx layers, ileal segments were exposed to a hyaluronidase solution in situ. The removal of the layers was confirmed by transmission electron microscopy, and the safety of the hyaluronidase pretreatment was established based on light microscopy, a constant mucosal membrane electrical resistance and the absence of lactate dehydrogenase leakage. In the in situ loop absorption experiment, hyaluronidase pretreatment significantly increased the plasma insulin level accompanied by an obvious hypoglycemic response. In the in vitro transport experiment, the apparent permeability coefficient of insulin was significantly increased by the hyaluronidase pretreatment, whereas that of 4.4 kDa fluorescein isothiocyanate-labeled dextran and of antipyrine, respective markers for passive para- and transcellular permeation, was unaffected. In the insulin degradation experiment in vitro, a significant amount of insulin was degraded in the compartment removed by hyaluronidase pretreatment. Thus, the mucous/glycocalyx layers functioned in insulin absorption as an enzymatic barrier and insignificantly affected diffusive absorption. In addition, co-administration of aprotinin, a protease inhibitor, further increased insulin absorption from ileum pretreated with hyaluronidase, implying the existence of another enzymatic barrier that influences insulin mucosal absorption. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:98 / 109
页数:12
相关论文
共 31 条
[1]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[2]   ABSORPTION CHARACTERISTICS OF CHEMICALLY MODIFIED-INSULIN DERIVATIVES WITH VARIOUS FATTY-ACIDS IN THE SMALL AND LARGE-INTESTINE [J].
ASADA, H ;
DOUEN, T ;
WAKI, M ;
ADACHI, S ;
FUJITA, T ;
YAMAMATO, A ;
MURANISHI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) :682-687
[3]  
BAI JP, 1995, J PHARM PHARMACOL, V46, P671
[4]   SUBCELLULAR-DISTRIBUTION OF PROTEOLYTIC ACTIVITIES DEGRADING BIOACTIVE PEPTIDES AND ANALOGS IN THE RAT SMALL-INTESTINAL AND COLONIC ENTEROCYTES [J].
BAI, JPF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) :671-675
[5]   The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins [J].
Bernkop-Schnurch, A .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :1-16
[6]   Evidence for the existence of insulin-degrading enzyme on the brush-border membranes of rat enterocytes [J].
Chang, LL ;
Bai, JPF .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :801-803
[7]   Immunohistochemical localization of insulin-degrading enzyme along the rat intestine, in the human colon adenocarcinoma cell line (Caco-2), and in human ileum [J].
Chang, LL ;
Stout, LE ;
Wong, WD ;
Buls, JG ;
Rothenberger, DA ;
Shier, WT ;
Sorenson, RL ;
Bai, JPF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :116-119
[8]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1453-1460
[9]   THE EFFECTS OF PERMEATION ENHANCERS ON THE SURFACE-MORPHOLOGY OF THE RAT NASAL-MUCOSA - A SCANNING ELECTRON-MICROSCOPY STUDY [J].
ENNIS, RD ;
BORDEN, L ;
LEE, WA .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :468-475
[10]  
Esko J.D., 1999, ESSENTIALS GLYCOBIOL, P145